ICT-enabled monitoring to improve health status and optimise hypertension care
ICT-enabled monitoring to improve health status and optimise hypertension care
HSMonitor is a pre-commercial procurement (PCP) project investing in Research and Development (R&D) services towards innovative ICT-enabled monitoring solutions to improve health status and optimise hypertension care.
Five healthcare providers from four countries (Turkey, Italy, Croatia and Sweden) are engaged in the procurement, catering to a combined population of 96 million, of which 31 million already have hypertension. The envisaged solutions should cover areas such as early detection and prevention, healthier lifestyle and nutrition, treatment adherence, training and education.
The envisaged solutions are developed in competitive phases by industry players (suppliers). The project is currently in Phase III.
PHASE I
Concept design
Solution architecture Technical specifications
- Develop a detailed specification of the proposed solution which addresses fit with technical, economic and organizational requirements of the suppliers.
- Expected output: detailed report describing the solution and a detailed plan for the prototyping and testing activities in Phases II & III.
- 3 months
- Maximum phase total budget: €693,000
- The offers are ranked according to quality – price ratio
- For Phase I 7 contracts were awarded
PHASE II
Development of prototype systems
in two iterations
- Develop the most promising ideas into well-defined prototypes
- Expected output:
- Prototype specification
- Prototype demonstration
- Plan for development of a limited volume of solutions for field-testing
- Updated cost/benefits forecast including a preliminary business plan
- 8 months
- Maximum phase total budget: €1,386,000
- The offers are ranked according to quality – price ratio
- For Phase II 3 contracts were awarded.
PHASE III
Development and testing of pilot systems
- Implement and assess the prototypes under real world conditions
- Expected output:
- Implementation in the 5 testing sites
- Overall assessment and success verification
- Updated cost/benefits forecast, including a preliminary business plan
- 16 months
- Maximum phase total budget: €2,541,000
- For Phase III 2 contracts were awarded
Share us
What's new?
Healthcare providers interested in innovative hypertension management approaches: stay up to date on latest solutions and results from HSMonitor’s large-scale pilots
The majority of Europeans today continue to develop high blood pressure (hypertension) in adulthood or later in life. In many countries, up to every third
Revisit the HSMonitor conference on the emerging results from piloting the two phase 3 solutions
HSMonitor organised a hybrid event on 13 July 2023 dedicated to tackling the rising incidence of hypertension among our population through the use of digital
HSMonitor organises conference on the emerging results from piloting the two phase 3 solutions
HSMonitor is organising a hybrid event on 13 July 2023 dedicated to tackling the rising incidence of hypertension among our population through the use of